In the latest session, Allogene Therapeutics Inc (NASDAQ: ALLO) closed at $5.63 up 4.26% from its previous closing price of $5.40. In other words, the price has increased by $+0.23 from its previous closing price. On the day, 1711850 shares were traded.
Ratios:
For a deeper understanding of Allogene Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.58 and its Current Ratio is at 12.58. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.15.
On December 08, 2023, Citigroup started tracking the stock assigning a Buy rating and target price of $7.Citigroup initiated its Buy rating on December 08, 2023, with a $7 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 30 ’24 when Parker Geoffrey M. bought 190 shares for $3.60 per share. The transaction valued at 683 led to the insider holds 819,590 shares of the business.
MESSEMER DEBORAH M. sold 18,640 shares of ALLO for $50,317 on Dec 18 ’23. The Director now owns 62,456 shares after completing the transaction at $2.70 per share. On Aug 07 ’23, another insider, Mayo Stephen, who serves as the Director of the company, sold 10,000 shares for $4.29 each. As a result, the insider received 42,855 and left with 25,328 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALLO now has a Market Capitalization of 946.56M and an Enterprise Value of 571.15M. For the stock, the TTM Price-to-Sale (P/S) ratio is 4986.40 while its Price-to-Book (P/B) ratio in mrq is 1.62. Its current Enterprise Value per Revenue stands at 3.07k whereas that against EBITDA is -1.76.
Stock Price History:
Over the past 52 weeks, ALLO has reached a high of $6.89, while it has fallen to a 52-week low of $2.23. The 50-Day Moving Average of the stock is 3.87, while the 200-Day Moving Average is calculated to be 3.95.
Shares Statistics:
For the past three months, ALLO has traded an average of 3.07M shares per day and 2.23M over the past ten days. A total of 144.44M shares are outstanding, with a floating share count of 103.86M. Insiders hold about 38.28% of the company’s shares, while institutions hold 61.13% stake in the company. Shares short for ALLO as of Feb 15, 2024 were 23.45M with a Short Ratio of 7.65, compared to 30.21M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 13.93% and a Short% of Float of 20.51%.
Earnings Estimates
There are 16 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.45 for the current quarter, with a high estimate of -$0.34 and a low estimate of -$0.62, while EPS last year was -$0.66. The consensus estimate for the next quarter is -$0.44, with high estimates of -$0.33 and low estimates of -$0.64.
Analysts are recommending an EPS of between -$1.89 and -$2.18 for the fiscal current year, implying an average EPS of -$2.01. EPS for the following year is -$1.76, with 17 analysts recommending between -$1.36 and -$2.4.
